Three-Fraction Intra-Cavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen

We report outcomes of a prospective trial evaluating adjuvant 3-fraction intra-cavitary accelerated partial breast brachytherapy for women with early stage breast cancer. With early follow-up, we have identified low rates of adverse events, favorable patient-reported quality of life, and a high rate of excellent or good breast cosmesis. These data are promising and warrant further study.

http://bit.ly/2Luoz5p